Form 4: Integra LifeSciences Executive Michael McBreen Reports Changes in Beneficial Ownership

EVP & President, CSS, Michael J. McBreen, reports acquisition and disposal of Integra LifeSciences Holdings Corp shares, including stock options, on March 11-12, 2024.

Summary

• Michael J. McBreen, EVP & President, CSS of Integra LifeSciences Holdings Corp, filed a Form 4 on March 13, 2024, reporting changes in beneficial ownership.
• On March 11, 2024, McBreen disposed of 492 shares of common stock at $36.22 and another 3,430 shares at $36.22.
• On the same day, he acquired 12,220 and 8,283 shares of common stock at $0.
• On March 12, 2024, McBreen disposed of 1,572 shares of common stock at $35.88 and another 440 shares at $35.88.
• McBreen also acquired 28,226 non-qualified stock options with an exercise price of $36.22, vesting over four years from March 11, 2024.
• Following these transactions, McBreen directly owns 57,882 shares of common stock and 28,226 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document primarily reports transactions without expressing a clear positive or negative outlook. The stock option grant is mildly positive, while the stock disposal is mildly negative.

Positives

• The acquisition of 20,503 shares at $0 suggests potential future value or compensation benefits.
• The grant of 28,226 stock options indicates confidence in the company's future performance.

Negatives

• The disposal of 5,934 shares could be interpreted negatively, although it may be for tax purposes or diversification.

Risks

• Executive stock transactions can sometimes signal a change in company outlook, although this is not always the case.
• The vesting schedule of the stock options means the executive's incentives are aligned with the company's long-term performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options suggests a long-term commitment from the executive.

Industry Context

Executive stock transactions are common in publicly traded companies and are closely watched by investors for insights into management's view of the company's prospects. Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• Vesting schedules are a common mechanism to ensure long-term commitment.
• The reported transactions are typical for executives in similar roles at comparable companies.

Stakeholder Impact

• Shareholders may interpret the transactions as a signal of the executive's confidence or lack thereof in the company's future performance.
• Employees may view the stock option grant as a positive sign of the company's commitment to its leadership.

Key Dates